9 Einträge gefunden

1. Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study

   1. Klein, Toni Maria
   2. Blome, Christine
   3. Kleyn, C Elise
   4. Conrad, Curdin
   5. Sator, Paul G
   6. Ståhle, Mona
   7. Eyerich, Kilian

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Psoriasis Healthcare and Facts in Latin America. For Decision Makers and Stakeholders

   1. Suthakharan, Nirohshah
   2. Griffiths, Christopher E M
   3. Maul, Julia-Tatjana
   4. Augustin, Matthias

   2022 - Forschungsinformationssystem des UKE
3. How do dermatologists' personal models inform a patient-centred approach to management: a qualitative study using the example of prescribing a new treatment (Apremilast)

   1. Hewitt, Rachael M
   2. Bundy, Chris
   3. Newi, Antonia-Luise
   4. Chachos, Evangelos
   5. Sommer, Rachel
   6. Kleyn, C Elise
   7. Augustin, Matthias

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure

   1. Armstrong, April
   2. Paul, Carle
   3. Puig, Luis
   4. Boehncke, Wolf Henning
   5. Freeman, Michael
   6. Torii, Hideshi
   7. Papp, Kim

   2020 - Forschungsinformationssystem des UKE
5. Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

   1. Leonardi, Craig
   2. Reich, Kristian
   3. Foley, Peter
   4. Torii, Hideshi
   5. Gerdes, Sascha
   6. Guenther, Lyn
   7. Gooderham, Melinda

   2020 - Forschungsinformationssystem des UKE
6. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study

   1. Parisi, Rosa
   2. Iskandar, Ireny Y K
   3. Kontopantelis, Evangelos
   4. Augustin, Matthias
   5. Griffiths, Christopher E M
   6. Ashcroft, Darren M

   2020 - Forschungsinformationssystem des UKE
7. Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials

   1. Reich, Kristian
   2. Griffiths, Christopher E M
   3. Gordon, Kenneth B
   4. Papp, Kim A
   5. Song, Michael
   6. Randazzo, Bruce
   7. Li, Shu

   2020 - Forschungsinformationssystem des UKE
8. Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders. A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)

   1. Blauvelt, Andrew
   2. Papp, Kim A
   3. Griffiths, Christopher E M
   4. Puig, Luis
   5. Weisman, Jamie
   6. Dutronc, Yves
   7. Kerr, Lisa Farmer

   2017 - Forschungsinformationssystem des UKE
9. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

   1. Griffiths, Christopher E M
   2. Reich, Kristian
   3. Lebwohl, Mark
   4. van de Kerkhof, Peter
   5. Paul, Carle
   6. Menter, Alan
   7. Cameron, Gregory S

   2015 - Forschungsinformationssystem des UKE